Ajit Ramalingam - Sep 1, 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
SVP, Chief Accounting Officer
Signature
/s/ Ajit Ramalingam
Stock symbol
BIO
Transactions as of
Sep 1, 2022
Transactions value $
-$28,689
Form type
4
Date filed
9/6/2022, 02:00 PM
Previous filing
Aug 8, 2022
Next filing
Sep 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +169 +171.57% $0.00 267 Sep 1, 2022 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$28.7K -59 -22.06% $486.25 208 Sep 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Award $0 +694 $0.00 694 Sep 1, 2022 Bio-Rad A Common Stock 694 $0.00 Direct F2, F3
transaction BIO Restricted Stock Units Options Exercise $0 -169 -25% $0.00 507 Sep 1, 2022 Bio-Rad A Common Stock 169 $0.00 Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F4 On September 1, 2021, the reporting person was granted 676 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.